Additionally, the deposition of monomeric C-reactive protein (mCRP) in the brain has been directly linked to amyloid and tau pathology, and consequently, cognitive dysfunction and Alzheimer’s disease development [77]. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.